Guidelines for therapeutic drug monitoring of vancomycin in the framework of model-informed precision dosing.

Clinical Practice Guidelines for Therapeutic Drug Monitoring of Vancomycin in the Framework of Model-Informed Precision Dosing: A Consensus Review by the Japanese Society of Chemotherapy and the Japanese Society of Therapeutic Drug Monitoring – Pharmaceutics

Related Guideline:

Guideline: Therapeutic monitoring of vancomycin for serious methicillin-resistant Staphylococcus aureus infections: A revised consensus guideline and review by the American Society of Health-System Pharmacists, the Infectious Diseases Society of America, the Pediatric Infectious Diseases Society, and the Society of Infectious Diseases Pharmacists

Summary: Therapeutic Monitoring of Vancomycin for Serious Methicillin-resistant Staphylococcus aureus Infections: A Revised Consensus Guideline and Review by the American Society of Health-system Pharmacists, the Infectious Diseases Society of America, the Pediatric Infectious Diseases Society, and the Society of Infectious Diseases Pharmacists – Clinical Infectious Diseases

Commentary on Twitter

?Rings Cowbell?
New Vancomycin guidelines drop from Japan.

This is the most written about the need for #PrecisionDosing that I have seen.

Give patients the dose they need because #OneSizeFitsNone@SIDPharm @ABsteward @IDstewardship https://t.co/wlwgkqZmXu

— Marc H. Scheetz (@IDPharmacometrx) April 13, 2022